hypergonadotropic hypogonadism hh also known primary peripheralgonadal hypogonadism primary gonadal failure condition characterized hypogonadism due impaired response gonads gonadotropins folliclestimulating hormone fsh luteinizing hormone lh turn lack sex steroid compensation lack negative feedback gonadotropin levels elevated individuals hh intact functioning hypothalamus pituitary glands hypothalamicpituitarygonadal hpa axis still able produce fsh hh may present either congenital acquired majority cases former hh treated hormone replacement symptoms vary greatly depending stage life biological sex etiology birth early infancy hh males present normal male phenotype without cryptorchidism complex genital anomaly normal female children often small nonpalpable testes present without genital individuals progress onto adolescence may experience absent delayed puberty puberty starts fails adult males hh may exhibit gynecomastia erectile dysfunction reduced testicular volume absence testicular enlargement puberty abnormal testicular texture consistency small stature decreased libido sexual activity infertility due low oligospermia azoospermia sperm count loss body hair loss muscle mass hot flashes psychological disturbances poor sleep females may present low levels estrogen abnormal individuals turner syndrome may short stature dysmorphic features gonadal dysgenesis delayed signs symptoms associated hh consist intellectual disability learning difficulties delayed puberty including amenorrhea absent breast pubic hair complications arise include anxiety depression osteoporosis relationship multitude etiologies hh include congenital acquired causes due damage dysfunction gonads include testicular ovarian torsion vanishinganorchia orchitis premature ovarian failure ovarian resistance syndrome trauma surgery autoimmunity chemotherapy radiation infections eg sexuallytransmitted diseases toxins eg endocrine disruptors infection kidney disease liver disease iron overload drugs eg antiandrogens opioids diagnosis made following family history including age healthy pubertal development family members possibility genetic disease evaluated prenatal history maternal medication use birthweight affected individual childhood surgical interventions overall general health also play significant role children delayed puberty hypogonadism distinguished constitutional delay family history constitutional delay closely associated positive family individuals examined height weight abnormal body breast genitalia examinations presence chaperone may also diagnostic imaging ultrasound computerized tomography ct magnetic resonance imaging mri done evaluate abnormalities internal genitalia tumors pituitary gland brain ovarian cysts possibilities polycystic ovarian syndrome individuals hypergonadotropic hypogonadism also exhibit gonadotropin levels fsh lh normal range gonadal hormone levels estrogen females testosterone males normal range biochemical parameters measured via blood however young males adolescence antim√ºllerian hormone amh levels may indicative hh since small amounts testosterone produced prior reactivation hpg axis karyotyping molecular genetic testing also done evaluate chromosomal blood tests check levels prolactin iron thyroid hormones done diagnose hh semen analysis another way measure sperm count help diagnose individuals hh treatment hh usually hormone replacement therapy consisting androgen estrogen administration males females therapies individualized based individuals needs help develop maintain secondary sexual males androgen therapy usually either done induction endogenous testosterone production hcg exogenous testosterone replacement therapy however important note testosterone treatment restore fertility many infertility treatment options available individuals hh selective estrogen receptor modulators serms aromatase inhibitors ais testicular sperm extraction intracytoplasmic sperm injections semenembryo cryopreservation also possible treatment options females hh estrogen therapy done initially breast development pubertal induction pubertal induction start later age maximize height growth benefits outweigh adverse estrogen therapy commonly using ethinylestradiol start low doses gradually increased according body studies regarding estrogen therapy focused girls turner syndrome many formulations estrogen therapy include oral estradiol oral conjugated estrogen transdermal estrogen patches estrogen gel therapy individualized initiated based many factors including age bone age absolute height psychosocial issues progesterone therapy week per month addition estrogen allows adequate uterine breast routine followups pubertal inductions include checkups height weight bodymass index bmi blood pressure three times year fshlh measurements every males hh studies focused klinefelters syndrome constitutional delay growth puberty cdgp therapy initiated adults doses gradually increased months testosterone ester given intramuscularly every weeks therapy lifelong boys permanent hypogonadism neonatal testosterone therapy given infants however children testosterone avoided due possible adverse effects rapid bone aging growth various formulation testosterone including oral intramuscular transdermal patches testosterone therapy avoid individuals breast andor prostate httpsenwikipediaorgwikihypergonadotropichypogonadism